BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sirius Therapeutics readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Sirius Therapeutics's drugs run\,
  from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07318155-1143@assetmemo.bio
DTSTAMP:20261121T010140Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:SRSD107: Phase 2 readout est. (NCT07318155)
DESCRIPTION:SRSD107\, phase 2\, Atherosclerotic Cardiovascular Disease.\nSt
 udy: A Study of SRSD107 in Participants With Chronic Coronary and/or Perip
 heral Arterial Disease\nEstimated primary completion: December 2027. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/srsd107#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07318155
URL:https://assetmemo.bio/drug/srsd107#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
